---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-060657"
form_type: "8-K"
ticker: "EMMA"
cik: "0000822370"
company_name: "Emmaus Life Sciences, Inc."
filed_at: "2022-09-30T23:59:59+00:00"
generated_at: "2026-06-23T06:33:34.055273+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Director Masaharu Osato resigns from Emmaus Life Sciences board; two vacancies created

## Summary
- Dr. Masaharu Osato resigned from the Board of Directors effective September 28, 2022, for personal reasons.
- His departure leaves two vacancies on the five-person Board.
- The Board is actively seeking candidates to fill the vacancies.

## SEC filing metadata
- accession: 0001213900-22-060657
- form_type: 8-K
- ticker: EMMA
- cik: 0000822370
- company_name: Emmaus Life Sciences, Inc.
- filed_at: 2022-09-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/822370/000121390022060657/0001213900-22-060657-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/822370/000121390022060657/ea166524-8k_emmauslife.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-060657
- JSON: https://secwatch.observer/filing/0001213900-22-060657.json
- Plain text: https://secwatch.observer/filing/0001213900-22-060657.txt

## Key facts
- Executive change
  Masaharu Osato resigned as Member of the Board of Directors at Emmaus Life Sciences, Inc..
  - Action: resigned
  - Role: Member of the Board of Directors
  source text: On September 28, 2022, Dr. Masaharu Osato resigned as a member of the Board of Directors of Emmaus Life Sciences, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/822370/000121390022060657/0001213900-22-060657-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.